These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21797279)

  • 41. Towards tailor-made oligosaccharides-chemo-enzymatic approaches by enzyme and substrate engineering.
    Homann A; Seibel J
    Appl Microbiol Biotechnol; 2009 May; 83(2):209-16. PubMed ID: 19357843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
    Schneider T; Senn MM; Berger-Bächi B; Tossi A; Sahl HG; Wiedemann I
    Mol Microbiol; 2004 Jul; 53(2):675-85. PubMed ID: 15228543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the active site of S. aureus monofunctional glycosyltransferase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin.
    Heaslet H; Shaw B; Mistry A; Miller AA
    J Struct Biol; 2009 Aug; 167(2):129-35. PubMed ID: 19416756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic investigation of the synthetic utility of glycopeptide glycosyltransferases.
    Oberthür M; Leimkuhler C; Kruger RG; Lu W; Walsh CT; Kahne D
    J Am Chem Soc; 2005 Aug; 127(30):10747-52. PubMed ID: 16045364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substrate binding affinity of Pseudomonas aeruginosa membrane-bound lytic transglycosylase B by hydrogen-deuterium exchange MALDI MS.
    Reid CW; Brewer D; Clarke AJ
    Biochemistry; 2004 Sep; 43(35):11275-82. PubMed ID: 15366937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
    Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
    Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
    Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
    Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of a library of xylogluco-oligosaccharides for active-site mapping of xyloglucan endo-transglycosylase.
    Fauré R; Saura-Valls M; Brumer H; Planas A; Cottaz S; Driguez H
    J Org Chem; 2006 Jul; 71(14):5151-61. PubMed ID: 16808501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of lipid-linked arabinofuranose donors for glycosyltransferases.
    Kraft MB; Martinez Farias MA; Kiessling LL
    J Org Chem; 2013 Mar; 78(5):2128-33. PubMed ID: 23373821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the lipid II sugar moiety on bacterial transglycosylase: the 4-hydroxy epimer of lipid II is a TGase inhibitor.
    Chen KT; Lin CK; Guo CW; Chang YF; Hu CM; Lin HH; Lai Y; Cheng TR; Cheng WC
    Chem Commun (Camb); 2017 Jan; 53(4):771-774. PubMed ID: 27999831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II.
    Jia Z; O'Mara ML; Zuegg J; Cooper MA; Mark AE
    Biophys J; 2011 Dec; 101(11):2684-92. PubMed ID: 22261057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystal structures of Weissella viridescens FemX and its complex with UDP-MurNAc-pentapeptide: insights into FemABX family substrates recognition.
    Biarrotte-Sorin S; Maillard AP; Delettré J; Sougakoff W; Arthur M; Mayer C
    Structure; 2004 Feb; 12(2):257-67. PubMed ID: 14962386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-Amino-2-pyridyl 1-thioglycosides in synthesis of analogs of glycosyltransferases substrates.
    Pastuch-Gawolek G; Bieg T; Szeja W; Flasz J
    Bioorg Chem; 2009 Jun; 37(3):77-83. PubMed ID: 19464725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Ser216 in the mechanism of action of membrane-bound lytic transglycosylase B: further evidence for substrate-assisted catalysis.
    Reid CW; Legaree BA; Clarke AJ
    FEBS Lett; 2007 Oct; 581(25):4988-92. PubMed ID: 17910958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic.
    Santiago M; Lee W; Fayad AA; Coe KA; Rajagopal M; Do T; Hennessen F; Srisuknimit V; Müller R; Meredith TC; Walker S
    Nat Chem Biol; 2018 Jun; 14(6):601-608. PubMed ID: 29662210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inhibitory effect on anti-lipid IV antiserum binding activity of various synthetic oligosaccharides].
    Hada N; Sugita M; Takeda T; Maki T; Ogihara Y
    Yakugaku Zasshi; 1994 May; 114(5):333-41. PubMed ID: 8014842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An efficient chemoenzymatic strategy for the synthesis of wild-type and vancomycin-resistant bacterial cell-wall precursors: UDP-N-acetylmuramyl-peptides.
    Liu H; Sadamoto R; Sears PS; Wong CH
    J Am Chem Soc; 2001 Oct; 123(40):9916-7. PubMed ID: 11583564
    [No Abstract]   [Full Text] [Related]  

  • 58. Crystal structure of Medicago truncatula UGT85H2--insights into the structural basis of a multifunctional (iso)flavonoid glycosyltransferase.
    Li L; Modolo LV; Escamilla-Trevino LL; Achnine L; Dixon RA; Wang X
    J Mol Biol; 2007 Jul; 370(5):951-63. PubMed ID: 17553523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane.
    Chugunov A; Pyrkova D; Nolde D; Polyansky A; Pentkovsky V; Efremov R
    Sci Rep; 2013; 3():1678. PubMed ID: 23588060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multidomain architecture of beta-glycosyl transferases: implications for mechanism of action.
    Saxena IM; Brown RM; Fevre M; Geremia RA; Henrissat B
    J Bacteriol; 1995 Mar; 177(6):1419-24. PubMed ID: 7883697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.